LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats

by | Sep 16, 2021 | Biothreat Detection

Home » Biothreat Detection » LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats

GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army:

MiQLab is an RT-PCR sample-to-answer system developed for veterinary diagnostic and food safety applications. Amid the COVID-19 pandemic, LexaGene has also been exploring its use for the detection of SARS-CoV-2 and other human pathogens.

Under the terms of their Cooperative Research and Development Agreement, or CRADA, DEVCOM and LexaGene will test the MiQLab system’s ability to detect two biothreats — Bacillus anthracis, which causes anthrax, and Yersinia pestis, which causes plague — focusing on its sensitivity and quantitative detection capability.

Read more at GenomeWeb.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility

Recently, we welcomed members of North Shore Technology Council and MassBio Leadership Teams into our facility at 500 Cummings Center for a full tour of our office space and laboratory spaces.

Upcoming Events

No events in this category to show at this time.

Latest Resources


LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.